Informations générales (source: ClinicalTrials.gov)
Multicentric Randomized Study eValuating the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Versus On-request (VENUS)
Interventional
N/A
Institut du Cancer de Montpellier - Val d'Aurelle (Voir sur ClinicalTrials)
août 2024
mai 2028
05 avril 2025
The study compares the quality of sexual life of breast cancer patients under two types
of oncoSexology supportive care : personalized supportive care versus on-request. The aim
is to improve the quality of sexual life of these patients.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | Silène DELORME | Contact (sur clinicalTrials) | |||
| CLCC INSTITUT GUSTAVE ROUSSY | Marion AUPOMEROL, Dr | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Antoine Lacassagne - 06189 - Nice - France | Anne CREISSON, Dr | Contact (sur clinicalTrials) | |||
| Centre Léon Bérard - 69008 - Lyon - France | Philippe TOUSSAINT, Dr | Contact (sur clinicalTrials) | |||
| CHU de Nîmes - 30029 - Nîmes - France | Frédéric FITENI, Dr | Contact (sur clinicalTrials) | |||
| ICM Val d'Aurelle - 34298 - Montpellier - France | Véronique D'HONDT, Dr | Contact (sur clinicalTrials) | |||
| Institut de Cancérologie de Lorraine - 54519 - Vandœuvre-lès-Nancy - Vandoeuvre LES Nancy - France | Claire CHARRA-BRUNAUD, Dr | Contact (sur clinicalTrials) | |||
| Institut de Cancérologie de l'Ouest - 44805 - Saint-Herblain - Saint Herblain - France | Aliette DEZELLUS, Dr | Contact (sur clinicalTrials) | |||
| IUCT - Oncopole - 31100 - Toulouse - France | Eva JOUVE, Dr | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Woman or man at least 18 years old
- Diagnosis of infiltrating breast cancer regardless of the biological characteristics
of the tumor
- Standard treatment by surgery, radiotherapy and/or chemotherapy, completed a maximum
of 3 months ago with the exception of post-neoadjuvant treatments (chemotherapy,
poly(ADP-ribose) polymerase (PARP) inhibitor, immunotherapy, targeted treatment,
...) which must have been started less than 3 months previously
- Patient with sufficient command of the French language to be able to answer the
questionnaires
- Patient having given informed, written and express consent.
- Affiliation to the French Social Security System
- Willingness and ability to comply with scheduled visits, treatment plan and other
study procedures
- Woman or man at least 18 years old
- Diagnosis of infiltrating breast cancer regardless of the biological characteristics
of the tumor
- Standard treatment by surgery, radiotherapy and/or chemotherapy, completed a maximum
of 3 months ago with the exception of post-neoadjuvant treatments (chemotherapy,
poly(ADP-ribose) polymerase (PARP) inhibitor, immunotherapy, targeted treatment,
...) which must have been started less than 3 months previously
- Patient with sufficient command of the French language to be able to answer the
questionnaires
- Patient having given informed, written and express consent.
- Affiliation to the French Social Security System
- Willingness and ability to comply with scheduled visits, treatment plan and other
study procedures
- Patient already taken cared of in oncosexology. The following are not criteria for
non-inclusion (a previous single consultation without treatment, use of local
vaginal treatments)
- Metastatic disease
- Patient under guardianship, curatorship or safeguard of justice